Gross Tumor Delineation in Esophageal Cancer on MRI Compared With 18F-FDG-PET/CT
Purpose: Current delineation of the gross tumor volume (GTV) in esophageal cancer relies on computed tomography (CT) and combination with 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET). There is increasing interest in integrating magnetic resonance imaging (MRI) in radiation treatme...
Main Authors: | , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-10-01
|
Series: | Advances in Radiation Oncology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2452109419300521 |
id |
doaj-7c3a297a718342fba7604b7730874f72 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Sophie E. Vollenbrock, MD Marlies E. Nowee, MD, PhD Francine E.M. Voncken, MD Alexis N.T.J. Kotte, PhD Lucas Goense, MD, PhD Peter S.N. van Rossum, MD, PhD Astrid L.H.M.W. van Lier, PhD Stijn W. Heijmink, MD, PhD Annemarieke Bartels-Rutten, MD, PhD Frank J. Wessels, MD Berthe M.P. Aleman, MD, PhD Luc Dewit, MD, PhD Linda G.W. Kerkmeijer, MD, PhD Edwin P.M. Jansen, MD, PhD Martijn Intven, MD, PhD Irene M. Lips, MD, PhD Gert J. Meijer, PhD Jasper Nijkamp, PhD |
spellingShingle |
Sophie E. Vollenbrock, MD Marlies E. Nowee, MD, PhD Francine E.M. Voncken, MD Alexis N.T.J. Kotte, PhD Lucas Goense, MD, PhD Peter S.N. van Rossum, MD, PhD Astrid L.H.M.W. van Lier, PhD Stijn W. Heijmink, MD, PhD Annemarieke Bartels-Rutten, MD, PhD Frank J. Wessels, MD Berthe M.P. Aleman, MD, PhD Luc Dewit, MD, PhD Linda G.W. Kerkmeijer, MD, PhD Edwin P.M. Jansen, MD, PhD Martijn Intven, MD, PhD Irene M. Lips, MD, PhD Gert J. Meijer, PhD Jasper Nijkamp, PhD Gross Tumor Delineation in Esophageal Cancer on MRI Compared With 18F-FDG-PET/CT Advances in Radiation Oncology |
author_facet |
Sophie E. Vollenbrock, MD Marlies E. Nowee, MD, PhD Francine E.M. Voncken, MD Alexis N.T.J. Kotte, PhD Lucas Goense, MD, PhD Peter S.N. van Rossum, MD, PhD Astrid L.H.M.W. van Lier, PhD Stijn W. Heijmink, MD, PhD Annemarieke Bartels-Rutten, MD, PhD Frank J. Wessels, MD Berthe M.P. Aleman, MD, PhD Luc Dewit, MD, PhD Linda G.W. Kerkmeijer, MD, PhD Edwin P.M. Jansen, MD, PhD Martijn Intven, MD, PhD Irene M. Lips, MD, PhD Gert J. Meijer, PhD Jasper Nijkamp, PhD |
author_sort |
Sophie E. Vollenbrock, MD |
title |
Gross Tumor Delineation in Esophageal Cancer on MRI Compared With 18F-FDG-PET/CT |
title_short |
Gross Tumor Delineation in Esophageal Cancer on MRI Compared With 18F-FDG-PET/CT |
title_full |
Gross Tumor Delineation in Esophageal Cancer on MRI Compared With 18F-FDG-PET/CT |
title_fullStr |
Gross Tumor Delineation in Esophageal Cancer on MRI Compared With 18F-FDG-PET/CT |
title_full_unstemmed |
Gross Tumor Delineation in Esophageal Cancer on MRI Compared With 18F-FDG-PET/CT |
title_sort |
gross tumor delineation in esophageal cancer on mri compared with 18f-fdg-pet/ct |
publisher |
Elsevier |
series |
Advances in Radiation Oncology |
issn |
2452-1094 |
publishDate |
2019-10-01 |
description |
Purpose: Current delineation of the gross tumor volume (GTV) in esophageal cancer relies on computed tomography (CT) and combination with 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET). There is increasing interest in integrating magnetic resonance imaging (MRI) in radiation treatment, which can potentially obviate CT- or FDG-PET/CT–based delineation. The aim of this study is to evaluate the feasibility of target delineation on T2-weighted (T2W) MRI and T2W including diffusion-weighted MRI (T2W + DW-MRI) compared with current-practice FDG-PET/CT. Methods: Ten observers delineated primary esophageal tumor GTVs of 6 patients on FDG-PET/CT, T2W-MRI, and T2W + DW-MRI. GTVs, generalized conformity indices, in-slice delineation variation (root mean square), and standard deviations in the position of the most cranial and caudal delineated slice were calculated. Results: Delineations on MRI showed smaller GTVs compared with FDG-PET/CT–based delineations. The main variation was seen at the cranial and caudal border. No differences were observed in conformity indices (FDG-PET/CT, 0.68; T2W-MRI, 0.66; T2W + DW-MRI, 0.68) and in-slice variation (root mean square, 0.13 cm on FDG-PET/CT; 0.10 cm on T2W-MRI; 0.14 cm on T2W + DW-MRI). In the 2 tumors involving the gastroesophageal junction, addition of DW-MRI to T2W-MRI significantly decreased caudal border variation. Conclusions: MRI-based target delineation of the esophageal tumor is feasible with interobserver variability comparable to that with FDG-PET/CT, despite limited experience with delineation on MRI. Most variation was seen at cranial-caudal borders, and addition of DW-MRI to T2W-MRI may reduce caudal delineation variation of gastroesophageal junction tumors. |
url |
http://www.sciencedirect.com/science/article/pii/S2452109419300521 |
work_keys_str_mv |
AT sophieevollenbrockmd grosstumordelineationinesophagealcanceronmricomparedwith18ffdgpetct AT marliesenoweemdphd grosstumordelineationinesophagealcanceronmricomparedwith18ffdgpetct AT francineemvonckenmd grosstumordelineationinesophagealcanceronmricomparedwith18ffdgpetct AT alexisntjkottephd grosstumordelineationinesophagealcanceronmricomparedwith18ffdgpetct AT lucasgoensemdphd grosstumordelineationinesophagealcanceronmricomparedwith18ffdgpetct AT petersnvanrossummdphd grosstumordelineationinesophagealcanceronmricomparedwith18ffdgpetct AT astridlhmwvanlierphd grosstumordelineationinesophagealcanceronmricomparedwith18ffdgpetct AT stijnwheijminkmdphd grosstumordelineationinesophagealcanceronmricomparedwith18ffdgpetct AT annemariekebartelsruttenmdphd grosstumordelineationinesophagealcanceronmricomparedwith18ffdgpetct AT frankjwesselsmd grosstumordelineationinesophagealcanceronmricomparedwith18ffdgpetct AT berthempalemanmdphd grosstumordelineationinesophagealcanceronmricomparedwith18ffdgpetct AT lucdewitmdphd grosstumordelineationinesophagealcanceronmricomparedwith18ffdgpetct AT lindagwkerkmeijermdphd grosstumordelineationinesophagealcanceronmricomparedwith18ffdgpetct AT edwinpmjansenmdphd grosstumordelineationinesophagealcanceronmricomparedwith18ffdgpetct AT martijnintvenmdphd grosstumordelineationinesophagealcanceronmricomparedwith18ffdgpetct AT irenemlipsmdphd grosstumordelineationinesophagealcanceronmricomparedwith18ffdgpetct AT gertjmeijerphd grosstumordelineationinesophagealcanceronmricomparedwith18ffdgpetct AT jaspernijkampphd grosstumordelineationinesophagealcanceronmricomparedwith18ffdgpetct |
_version_ |
1725880150866788352 |
spelling |
doaj-7c3a297a718342fba7604b7730874f722020-11-24T21:51:09ZengElsevierAdvances in Radiation Oncology2452-10942019-10-0144596604Gross Tumor Delineation in Esophageal Cancer on MRI Compared With 18F-FDG-PET/CTSophie E. Vollenbrock, MD0Marlies E. Nowee, MD, PhD1Francine E.M. Voncken, MD2Alexis N.T.J. Kotte, PhD3Lucas Goense, MD, PhD4Peter S.N. van Rossum, MD, PhD5Astrid L.H.M.W. van Lier, PhD6Stijn W. Heijmink, MD, PhD7Annemarieke Bartels-Rutten, MD, PhD8Frank J. Wessels, MD9Berthe M.P. Aleman, MD, PhD10Luc Dewit, MD, PhD11Linda G.W. Kerkmeijer, MD, PhD12Edwin P.M. Jansen, MD, PhD13Martijn Intven, MD, PhD14Irene M. Lips, MD, PhD15Gert J. Meijer, PhD16Jasper Nijkamp, PhD17Department of Radiology, The Netherlands Cancer Institute, Amsterdam, The NetherlandsDepartment of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The NetherlandsDepartment of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The NetherlandsDepartment of Radiation Oncology, University Medical Center Utrecht, Utrecht, The NetherlandsDepartment of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands; Department of Surgery, University Medical Center Utrecht, Utrecht, The NetherlandsDepartment of Radiation Oncology, University Medical Center Utrecht, Utrecht, The NetherlandsDepartment of Radiation Oncology, University Medical Center Utrecht, Utrecht, The NetherlandsDepartment of Radiology, The Netherlands Cancer Institute, Amsterdam, The NetherlandsDepartment of Radiology, The Netherlands Cancer Institute, Amsterdam, The NetherlandsDepartment of Radiology, University Medical Center Utrecht, Utrecht, The NetherlandsDepartment of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The NetherlandsDepartment of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The NetherlandsDepartment of Radiation Oncology, University Medical Center Utrecht, Utrecht, The NetherlandsDepartment of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The NetherlandsDepartment of Radiation Oncology, University Medical Center Utrecht, Utrecht, The NetherlandsDepartment of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands; Department of Radiation Oncology, Leiden University Medical Center, Leiden, The NetherlandsDepartment of Radiation Oncology, University Medical Center Utrecht, Utrecht, The NetherlandsDepartment of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Surgery, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Corresponding author. Departments of Surgery and Radiation Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.Purpose: Current delineation of the gross tumor volume (GTV) in esophageal cancer relies on computed tomography (CT) and combination with 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET). There is increasing interest in integrating magnetic resonance imaging (MRI) in radiation treatment, which can potentially obviate CT- or FDG-PET/CT–based delineation. The aim of this study is to evaluate the feasibility of target delineation on T2-weighted (T2W) MRI and T2W including diffusion-weighted MRI (T2W + DW-MRI) compared with current-practice FDG-PET/CT. Methods: Ten observers delineated primary esophageal tumor GTVs of 6 patients on FDG-PET/CT, T2W-MRI, and T2W + DW-MRI. GTVs, generalized conformity indices, in-slice delineation variation (root mean square), and standard deviations in the position of the most cranial and caudal delineated slice were calculated. Results: Delineations on MRI showed smaller GTVs compared with FDG-PET/CT–based delineations. The main variation was seen at the cranial and caudal border. No differences were observed in conformity indices (FDG-PET/CT, 0.68; T2W-MRI, 0.66; T2W + DW-MRI, 0.68) and in-slice variation (root mean square, 0.13 cm on FDG-PET/CT; 0.10 cm on T2W-MRI; 0.14 cm on T2W + DW-MRI). In the 2 tumors involving the gastroesophageal junction, addition of DW-MRI to T2W-MRI significantly decreased caudal border variation. Conclusions: MRI-based target delineation of the esophageal tumor is feasible with interobserver variability comparable to that with FDG-PET/CT, despite limited experience with delineation on MRI. Most variation was seen at cranial-caudal borders, and addition of DW-MRI to T2W-MRI may reduce caudal delineation variation of gastroesophageal junction tumors.http://www.sciencedirect.com/science/article/pii/S2452109419300521 |